Drawing for NANT

USPTO serial 86263568

NANT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FROMM, MARTHA L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. McCue

MICHAEL J. MCCUE LEWIS ROCA ROTHGERBER LLP3993 HOWARD HUGHES PKWY STE 600LAS VEGAS, NV 89169-5996UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Health care cost review, health care cost containment, consulting services in the cost and payment management of health care; electronic data collection and data submission services for business purposes in developing, testing and validating next-generation diagnostics and pharmaceuticals to target pre-selected patients based on molecular profiles to predict drug response to particular therapeutics; promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; collection and compilation of information into computer databases in the field of patient data, bioinformatics, discovery research, molecular medicine, and clinical developments designed to match patients with their personalized treatment regimens and preferred healthcare providers; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; data collection and data processing services in the fields of medicine and healthcare; medical referrals for healthcare and medical treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 16, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 16, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 16, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 15, 2017EX5GSOU EXTENSION 5 GRANTED—
Sep 12, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 30, 2017EXT5SOU EXTENSION 5 FILED—
Aug 30, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 14, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 9, 2017EX4GSOU EXTENSION 4 GRANTED—
Mar 9, 2017EXT4SOU EXTENSION 4 FILED—
Mar 9, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 7, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 6, 2016EX3GSOU EXTENSION 3 GRANTED—
Aug 25, 2016EXT3SOU EXTENSION 3 FILED—
Aug 25, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 19, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 16, 2016EX2GSOU EXTENSION 2 GRANTED—
Apr 5, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 4, 2016EXT2SOU EXTENSION 2 FILED—
Mar 4, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 11, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 9, 2015EX1GSOU EXTENSION 1 GRANTED—
Sep 9, 2015EXT1SOU EXTENSION 1 FILED—
Sep 9, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 10, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 13, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 13, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 24, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 10, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 9, 2014ALIEASSIGNED TO LIE—
Nov 25, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 25, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Nov 25, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 25, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 25, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 24, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 24, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 24, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 23, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 16, 2014DOCKASSIGNED TO EXAMINER—
May 9, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 29, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance